Opioid Use Disorder

Core Concepts

How opioids work

Opioids bind to mu-opioid receptors in the brain, spinal cord, and gut, producing four clinically central effects: analgesia, euphoria/sedation, respiratory depression (the brain's breathing drive is dampened), and slowed gut motility. In overdose, respiratory depression is the killer: breathing slows, oxygen falls, and without intervention the person dies. Nurses monitor sedation and respiratory status after any opioid administration — a habit that matters for prescribed relief as much as illicit use.

Tolerance, physical dependence, and withdrawal

• Tolerance to euphoria and analgesia develops rapidly, so escalating doses produce less effect.
• Physical dependence means the body has adapted; stopping abruptly triggers withdrawal: yawning, tearing, runny nose, sweating, dilated pupils, muscle aches, cramping, diarrhea, anxiety — intensely uncomfortable but rarely life-threatening on its own.
• The dangerous contrast: overdose is the emergency — respiratory depression with pinpoint pupils and unresponsiveness. Overdose and withdrawal are opposites, and confusing them can be fatal.

Recognizing overdose: recognition and escalation

Signs of opioid overdose: slow or stopped breathing, pinpoint pupils, unresponsiveness, limpness, blue-tinged lips or fingertips. This is a medical emergency: the nurse activates the emergency response (call for help, follow facility code/protocol, notify the provider) — not improvisation. Naloxone, a medication that temporarily reverses opioid effects by blocking receptors, is the standard emergency reversal agent administered by trained responders per protocol. Educational note: recognition-and-escalation information only — always follow facility policy and the response team's direction.

From pain relief to disorder: a cautionary letter

The modern crisis has roots in the 1990s, when pain was declared the "fifth vital sign" and opioid prescribing expanded dramatically. A frequently cited catalyst: a 1980 one-paragraph letter to the New England Journal of Medicine by Porter and Jick, which reported that addiction appeared "rare" among hospitalized patients treated with opioids. The letter was a brief, uncontrolled chart review of inpatients without standardized addiction assessment or long-term follow-up — yet it was cited thousands of times to support aggressive prescribing. It is a textbook lesson in methodological caution: a single weak study can shape practice for decades (review flag: verify the letter's history and citation counts).

Treatment and the nursing role

• Medications for opioid use disorder (MOUD): methadone (a long-acting agonist dispensed through regulated programs), buprenorphine (a partial agonist from qualified prescribers), and naltrexone (an antagonist). These reduce craving, prevent withdrawal, and lower overdose risk — commonly cited as the strongest evidence-based treatments; access varies by jurisdiction and prescriber authorization.
• Psychosocial care: counseling, mutual support groups, and recovery supports, usually combined with medication.
• "Detox" alone has high relapse rates — medically managed withdrawal without ongoing treatment is not sufficient for most people.
• The nurse's role: nonjudgmental screening, objective documentation, pain assessment that takes the report seriously, education within scope, referral to the care team, and vigilant monitoring for respiratory depression.

Pain management with OUD: the double stigma

People with OUD who have genuine acute pain face a cruel bind: undertreatment because clinicians fear "drug-seeking," or uncoordinated over-treatment. Acute pain is real and managed by the care team like anyone else's, with a coordinated plan and clear communication. Person-first language ("person with opioid use disorder," never "addict" or "junkie") is part of the treatment.

Common Confusions